Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The U.S. government's principal agency for cancer research
The NCCAPS study will help scientists answer key questions about COVID-19’s impact on cancer patients.
The bottom-line message for breast cancer survivors is “move as often as you can, when you can.”
It was 27% more accurate than the standard approach at detecting any metastases.
“Cancer survivors need the expertise of someone who knows cancer and understands what is ‘normal’ for a cancer survivor.”
The first clinical trial will test a therapy designed to target a protein on cancer cells in young people with acute myeloid leukemia.
This makes a big difference in preventing the more than half a million new cervical cancer cases and over 300,000 deaths globally each year.
“With BAX, we have a single target for blocking both types of cell death stemming from the use of doxorubicin."
Women who have undergone standard radiation therapy have reported pain, diarrhea and fecal incontinence.
People whose gut microbiome become less diverse after a transplant have a higher risk of death from any cause in the weeks after treatment.
The Moonshot has been achieving its intended goals and is rapidly advancing the science for a range of research priorities.
The National Cancer Institute answers some of your questions regarding the novel coronavirus.
Retinoblastoma is an uncommon cancer of the eye that is curable when diagnosed in its early stages.
The maps may create opportunities to identify cancers much earlier than is currently possible, the study leaders believe.
“In the era of targeted therapy, it is critical to know that a therapy is the right choice and is going to be effective.”
“We are excited about these inhibitors and the potential for them to have an anticancer effect while also potentially preventing bone loss.”
A month after receiving the treatment, there were higher levels of CAR T cells in the blood of patients who got the new therapy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.